Access the latest educational resources selected for you by clicking each tab below.
For the full list, visit the Resource Library.
Basic research is the foundation of all scientific breakthroughs, improving our understanding of biology and advancing our knowledge of the life sciences. Learn more about our animal models and CRISPR technology.
|The Germ-Free Factories|
Though rewarding, drug discovery can be a challenging journey. Too often, a novel compound’s road to market is delayed – or blocked entirely – by limited resources or expertise. Learn how to mitigate those delays through our approach to target discovery, hit finding, lead optimization, and beyond.
|Hit-Finding – A Walk-Through of HIT ID Approaches and Next Steps|
|Charles River Presents: The Neuroinflammation Symposium|
Determination of a drug’s safety profile is perhaps one of the most critical stages of the drug development pathway. Complications and inefficiencies at this late phase of the journey can create costly delays. See the latest resources to help you overcome these common issues.
|Investigational New Drug (IND) Development Programs|
|Standard for Exchange of Nonclinical Data (SEND)|
|Society of Toxicology (SOT) Resource Center – Access our 40 ePosters|
Laboratory sciences is an integral part of drug development, from the earliest stages of nonclinical work, requiring the efficient development and transfer of methods, to produce detailed, on-time data to support decision making. Access the latest resources to stay up-to-date on ADME, metabolites, and the microbiome.
|Quantification of mRNA Expression Using DNA-based Standard Curve RT-qPCR Methods|
|Validation of an LC-MS/MS Assay To Measure Arginine, α-k-δ-GVA, Argininic Acid, Guanidinoacetic Acid, and Nα Acetyl-L-Arginine Concentrations in ARG1-D Patients ePoster|
|Tackling Program Challenges in Cellular Therapy Research and Development|
|Enabling DMPK Science: Delivering In Vitro ADME Data “Even Faster”|
|The Therapeutic Axis of Microbiome, Inflammation, and Immune Response|
The approval process for ensuring the identity, potency, purity, safety, and effectiveness of a biopharmaceutical is complex. Navigating this process effectively is critical to the ultimate commercial success of a product. Find out more about building your biologic, viral clearance, next generation sequencing and more with our array of digital resources.
|Building a Biologic|
|A Comparative Analysis of Viral Clearance by Affinity and AEX Chromatography|
Testing for microbial contaminants is necessary to ensure the safety and quality of their products, but the process can add costly delays in their release to market. Learn how to streamline testing and mitigate these risks with revolutionary technologies and exceptional services that have changed the way the industries conduct quality control. See a more comprehensive list here.
|Accugenix® Microbial Identification Library Comparison|